ISSN:
1432-2277
Keywords:
Key words Lipoproteins
;
liver transplantation
;
immunosuppression
;
Liver transplantation
;
lipoproteins
;
immunosuppression
;
Immunosuppression
;
liver transplantation
;
lipoproteins
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Dyslipidemia is common after liver transplantation, but the underlying mechanisms are largely unknown. We studied the lipid profile of 27 liver transplant recipients randomized to receive either cyclosporin (CyA, n = 14) or tacrolimus (n = 13) and compared them with 20 healthy, matched controls. Before transplantation, patients presented low total and low-density lipoprotein (LDL) cholesterol (as compared to controls) that increased shortly, i. e., 3 months, after transplantation. Eighteen months post-transplantation, total and LDL cholesterol levels decreased to pretransplant values but tended to remain higher in CyA-treated patients. However, at that time, prednisone treatment was more prevalent among CyA-treated than tacrolimus-treated patients and fully accounted for the difference in cholesterol levels. Indeed, regardless of therapy, patients not receiving prednisone exhibited lower cholesterol levels than prednisone-treated patients and controls. We conclude that prednisone therapy, rather than CyA or tacrolimus immunosuppression, seems to be the major determinant of increased cholesterol levels.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s001470050117
Permalink